Oxindole-based intraocular pressure reducing agents
Keywords: Melatonin; Intraocular pressure; Oxindole derivatives; Glaucoma treatment; IOP; intraocular pressure; QR2; NQO2, quinone reductase 2; MCA-NAT; 5-MCA-NAT - 5-methoxycarbonylamino-N-acetyltryptamine;